explains frank greenway chief outpatient clinic pennington biomedical research center baton rouge Louisiana obesity neuropsychiatric component makes especially troublesome treat new drugs facing fda review targets brain differently drug called contrave takes aim brain reward pathway compounds affect brain areas involved appetite drugs appear induce long term weight loss concern like antiobesity drugs targeted brain cause unwanted effects central peripheral nervous systems lorcaserin new drugs affects serotonin involves multiple brain processes appetite including emotion cardiovascular regulation company lorcaserin san diego based arena pharmaceuticals gone great lengths chemical not cause serotonin related heart valve problems associated fen phen drug lead depression